Supernus Presents at Two Healthcare Conferences in November – Supernus…

Supernus Presents at Two Healthcare Conferences in November – Supernus…

Facebook
Twitter
LinkedIn

ROCKVILLE, Md., Nov. 8, 2022 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. SUPNa biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system (CNS) disorders, today announced that Jack Khattar, President and CEO of Supernus Pharmaceuticals, will provide a company overview, updates and host investor meetings . at the following November conferences:

Stifel 2022 Health Conference
Date: Tuesday 15 November 2022
Time: 8:00 a.m. ET
Location: Lotte New York Palace Hotel, New York

13th Annual Jefferies Health Conference in London
Date: Thursday 17 November 2022
Time: 9:05am ET / 2:05pm GMT
Location: Waldorf Hilton, London, UK

Investors interested in scheduling a meeting with the Company’s management during these conferences should contact the appropriate conference coordinators.

A live webcast of the presentations can be accessed by visiting Events & Presentations in the Investor Relations section of the company’s website www.supernus.com. An archived replay of these webcasts will be available on the company’s website for 60 days after the respective conferences.

About Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of products to treat diseases of the central nervous system (CNS).

Our diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, ADHD, hypomobility in Parkinson’s disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adults patients. We are developing a broad range of novel CNS product candidates, including new potential treatments for hypomobility in Parkinson’s disease, epilepsy, depression and other CNS disorders.

For more information, please visit www.supernus.com.

Forward-Looking Statements

This press release contains forward-looking statements for the purposes of privacy…



Source story

More to explorer